| Uniprot No. | P0DTC9 |
| Target Names | N |
| Alternative Names | Nucleocapsid protein, NC, protein N, N |
| Species Reactivity | Human Novel Coronavirus (SARS-CoV-2/ 2019-nCoV) |
| Immunogen | Recombinant Human Novel Coronavirus Nucleoprotein (N) (1-419aa) (CSB-EP3325GMY) |
| Immunogen Species | Human Novel Coronavirus (SARS-CoV-2/ 2019-nCoV) |
| Conjugate | Non-conjugated |
| Clonality | Monoclonal |
| Isotype | Mouse scFv fusion with human IgG1 Fc |
| Clone No. | 1A6 |
| Purification Method | Affinity-chromatography |
| Concentration | It differs from different batches. Please contact us to confirm it. |
| Buffer | Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4 |
| Form | Liquid |
| Tested Applications | ELISA, WB |
| Recommended Dilution | | Application | Recommended Dilution | | WB | 1:500-1:5000 | |
| Protocols | ELISA Protocol
Western Blotting(WB) Protocol
CSB-RA33255A1GMY ELISA protocol |
| Storage | Upon receipt, store at -20°C or -80°C. Avoid repeated freeze. |
| Description | Recombinant anti-SARS-CoV-2 Nucleoprotein Mouse ScFv is expressed from 293 cells (HEK293) with a human IgG1 Fc tag on C-terminal. |
